Trials / Conditions / Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor
Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor
3 registered clinical trials studyying Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer NCT00551070 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopi NCT00301756 | National Cancer Institute (NCI) | Phase 2 |
| Completed | 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid NCT00031681 | National Cancer Institute (NCI) | Phase 1 |